Conference Coverage
NewsNetwork
OncLive TV
PEER EXCHANGE
OncLive INSIGHTS

OS by PS in Metastatic Pancreatic Cancer Treatment- Data From an Exploratory Subgroup Analysis

 

SPECIALTY TOPICS
CURRENTLY VIEWING
All Specialties
Breast Cancer
Multiple Myeloma
Lung Cancer
Immuno-Oncology News
Gynecologic Oncology
Gastrointestinal Cancer
Colorectal Cancer
Prostate Cancer
Neoadjuvant HER2+
Brain Cancer
More >>

Ovarian Cancer Videos

Potential Risks of Genetic Testing in Ovarian Cancer
Potential Risks of Genetic Testing in Ovarian Cancer
Peter Levonian, MS, senior genetic counselor, Stanford Medicine, discusses the potential risks of genetic testing in ovarian cancer.
Onclive TV   >   
Neoadjuvant Chemo VS Cytoreductive Surgery in OC
Neoadjuvant Chemo VS Cytoreductive Surgery in OC
Panelists review the criteria for choosing neoadjuvant chemotherapy, and comment on the role of cytoreductive surgery for advanced ovarian cancer (OC).
Peer Exchange   >   Advanced Ovarian Cancer: Optimizing Therapy Based on Current Data
Dr. Westin on Emerging PARP Inhibitors in Ovarian Cancer
Dr. Westin on Emerging PARP Inhibitors in Ovarian Cancer
Shannon N. Westin, MD, MPH, clinical investigator, Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, discusses PARP inhibitors being tested in clinical trials.
Onclive TV   >   
Dr. Markman Discusses the Future of Treatment for Ovarian Cancer
Dr. Markman Discusses the Future of Treatment for Ovarian Cancer
Maurie Markman, MD, president of Medicine and Science, Cancer Treatment Centers of America, editor-in-chief, OncologyLive, and 2018 Giant of Cancer Care® for Gynecological Cancers, discusses the future of treatment for patients with ovarian cancer.
 
Onclive TV   >   
Dr. Nguyen on Treatment Approaches for Patients With Advanced Ovarian Cancer
Dr. Nguyen on Treatment Approaches for Patients With Advanced Ovarian Cancer
Trung Nguyen, DO, MBA, clinical assistant professor, Obstetrics and Gynecology, Gynecologic Oncology, Stanford Medicine, discusses treatment approaches for patients with advanced ovarian cancer.
Onclive TV   >   
Dr. Dorigo on Immunotherapy in Ovarian Cancer
Dr. Dorigo on Immunotherapy in Ovarian Cancer
Oliver Dorigo, MD, PhD, associate professor of Obstetrics and Gynecology, Stanford University Medical Center, Stanford Medicine, discusses the use of immunotherapy in the treatment of patients with ovarian cancer.
Onclive TV   >   
Dr. Berek Discusses the Impact of PARP Inhibitors on Ovarian Cancer
Dr. Berek Discusses the Impact of PARP Inhibitors on Ovarian Cancer
Jonathan S. Berek, MD, MMS, Laurie Kraus Lacob Professor, Stanford University School of Medicine, director, Stanford Women’s Cancer Center, senior advisor, Stanford Cancer Institute, discusses the impact of PARP inhibitors on the treatment landscape of ovarian cancer.
 
Onclive TV   >   
The Importance of Genetic Testing Following a Diagnosis of Ovarian Cancer
The Importance of Genetic Testing Following a Diagnosis of Ovarian Cancer
Peter Levonian, MS, senior genetic counselor, Stanford Medicine, discusses the importance of genetic testing following a diagnosis of ovarian cancer.
Onclive TV   >   
Dr. Karam on Primary Debulking Surgery Versus Neoadjuvant Chemotherapy in Ovarian Cancer
Dr. Karam on Primary Debulking Surgery Versus Neoadjuvant Chemotherapy in Ovarian Cancer
Amer Karam, MD, associate clinical professor, Gynecologic Oncology, Stanford Hospital, director, Robotic Surgery and Outreach, Division of Gynecologic Oncology, Stanford Medicine, discusses primary debulking surgery versus neoadjuvant chemotherapy in the treatment of patients with ovarian cancer.
Onclive TV   >   
Dr. Powell on Tumor Mutational Burden in Ovarian Cancer
Dr. Powell on Tumor Mutational Burden in Ovarian Cancer
Matthew Powell, MD, associate professor, Obstetrics and Gynecology, Division of Gynecologic Oncology, Washington University School of Medicine, discusses tumor mutational burden (TMB) in ovarian cancer.
Onclive TV   >   
Next Page >>
Publications
Covering Every Angle of Oncology Practice. Click a cover below, to view more.
Publication Bottom Border
Border Publication
 
Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-939-0221

Copyright OncLive 2006-2018
Intellisphere, LLC. All Rights Reserved.
 
x